Delayed drug hypersensitivity reactions: How p-i transforms pharmacology into immunology
Delayed drug hypersensitivity reactions (dDHRs) are iatrogenic diseases, which are mostly due to non-covalent interactions of a drug with the immune receptors HLA and/or TCR causing T-cell activation. This is also known as pharmacological interaction with immune receptors or p-i. P-i activation diff...
Saved in:
Main Author: | Werner J. Pichler |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893024000881 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolocumab-induced delayed skin hypersensitivity reaction in a patient with familial hypercholesterolaemia
by: Grzegorz Porebski, et al.
Published: (2024-02-01) -
Evaluation of the basophil activation in immediate type
hypersensitivity reactions to chemotherapeutic agents
by: Gözde Köycü Buhari, et al.
Published: (2024-02-01) -
Side effects and hypersensitivity reactions to corticosteroids
by: M.Z. Lisiecka
Published: (2024-06-01) -
Plasma Concentrations of Benzylpenicillin and Cloxacillin in Infective Endocarditis—With Special Reference to Delayed Hypersensitivity Reactions
by: Malin Hägglund, et al.
Published: (2025-01-01) -
Paclitaxel-induced Hypersensitivity Reaction
by: Cyril Sajan, et al.
Published: (2024-12-01)